Bill Text: CA SB546 | 2017-2018 | Regular Session | Amended
Bill Title: Veterinary medicine.
Sponsorship: Partisan Bill (Democrat 1)
Status: (Failed) 2018-02-01 - Returned to Secretary of Senate pursuant to Joint Rule 56. [SB546 Detail]
Download: California-2017-SB546-Amended.html
|
Amended
IN
Senate
April 17, 2017 |
| Senate Bill | No. 546 |
| Introduced by Senator Hill |
February 16, 2017 |
LEGISLATIVE COUNSEL'S DIGEST
Existing
(3)
Digest Key
Vote: MAJORITY Appropriation: NO Fiscal Committee: YES Local Program: YESBill Text
The people of the State of California do enact as follows:
This act may be known as Lizzie’s Law.
SECTION 1.
Section 4809.7 of the Business and Professions Code is amended to read:4809.7.
The board shall establish a regular inspection program that will provide for random, unannounced inspections. The board shallSEC. 2.
Section 4830 of the Business and Professions Code is amended to read:4830.
(a) This chapter does not apply to:SEC. 3.
Section 4887 of the Business and Professions Code is amended to read:4887.
(a) (1) A person whose license or registration has been revoked or who has been placed on probation may petition the board for reinstatement or modification of penalty including modification or termination of probation after a periodSEC. 2.SEC. 4.
Article 7 (commencing with Section 4920) is added to Chapter 11 of Division 2 of the Business and Professions Code, to read:Article 7. Pharmacy
4920.
(a)(2)The veterinarian or authorized representative shall provide the counseling to the best of his or her ability, knowledge, and availability of
information, but neither the veterinarian nor the authorized representative shall be liable for the veracity and completeness of the information provided in the literature or handout if it is information obtained through a pharmaceutical laboratory or is based on accredited professional sources and publications. For this purpose, the veterinarian or authorized representative shall provide the client with a printed disclaimer explaining the lack of liability for the information in the literature or handout if it is obtained under those circumstances and the client shall sign the disclaimer.
(3)Unless there is a life-threatening warning or a critical update about the drug or medicine, a client may decline to receive the counseling, literature, or handout.
(4)The counseling, literature, and handout shall include all of the following information:
(A)
(B)How and when to give the drug or medicine to the pet or service animal and for how long.
(C)What to do if a dose is missed.
(D)Possible risks and side effects, and what the client should do if they occur.
(E)
(F)Whether the new drug or medicine and the prescribed dosage are appropriate for the pet or service animal’s age, weight, and kidney
and liver function.
(G)Whether the new drug or medicine will work safely with other drugs, medicines, or supplements.
(H)
(5)(A)
(B)If a long-acting or extended release drug or medicine is to be administered, the client shall also be counseled before the injection about the difference between standard and long-acting or extended release drugs or medicines. This counseling may include, but is not limited to, explaining adverse reactions due to prolonged systemic drug or medicine clearance of long-acting drugs or medicines in such a way
that the client understands that once the animal is injected there is no way to retrieve the drug or medicine.
(6)The literature or handout shall be provided in readable-sized font.
(b)At the discretion of the veterinarian, the counseling, literature, or handout may be provided by a
(c)(1)The literature or handout may be provided electronically or in any other format using available technology as long as it allows the client to confirm the material was received.
(2)The literature or handout shall be available to clients in English and may also be provided in Spanish and in any other language
appropriate for the veterinary practice.
(3)The literature or handout shall also be provided to clients with special needs or disabilities in an easily accessible format, such as, but not limited to, a large-sized font.
(4)
(d)
(C)The right to receive drug and medicine information in readable-sized font.
(D)
